Genomic Insights into Multidrug Resistance, Virulence, and Phage Defense in Poultry-Derived Shigella sonnei from Bangladesh
This study presents the first genomic characterization of a multidrug-resistant and virulent *Shigella sonnei* strain isolated from poultry in Bangladesh, revealing a high potential for horizontal gene transfer of resistance genes and underscoring the urgent need for a One Health approach to monitor antimicrobial resistance at the human-animal-environment interface.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
In the microscopic world that lives alongside us, bacteria are constantly evolving, trading genetic traits like cards in a deck. Some of these traits help them survive in harsh environments, while others allow them to resist the medicines we use to fight them. This exchange often happens between different species, meaning a bacterium found in a farm animal can pass its survival skills to a bacterium that infects a human. This process is a central concern in the field of antimicrobial resistance, where the effectiveness of our drugs is slowly eroding. When bacteria become resistant to multiple types of antibiotics, they become much harder to treat, posing a serious threat to public health. Understanding how these bacteria acquire these defenses, where they live, and how they move between animals and people is essential for keeping communities safe.
A team of researchers in Bangladesh has taken a close look at a specific bacterium found in poultry to understand these dynamics better. They isolated a strain of Shigella sonnei from a chicken rectal swab, marking the first time this specific bacterium has been reported in poultry within the country. While Shigella sonnei is well-known as a cause of human gastrointestinal illness, its presence in farm animals suggests a potential bridge for the disease to jump from animals to people. The researchers used advanced sequencing technology to read the entire genetic code of this bacterial strain, creating a detailed map of its DNA to see exactly what tools it carries for survival, infection, and defense.
The bacterium, named BCSIR-MHS-F2, was found to be a moderately strong builder of biofilms, which are slimy layers that bacteria create to stick to surfaces and protect themselves. When tested against common antibiotics, the strain showed a mixed response: it was sensitive to some drugs but strongly resistant to others, including ampicillin and ceftriaxone. It also showed moderate resistance to gentamicin and tazobactam. This pattern of resistance is concerning because it means that if this bacterium were to infect a person, standard treatments might fail. The genetic map revealed that the bacterium carries a large collection of genes that neutralize or pump out different types of antibiotics, including those used to treat infections caused by beta-lactams, tetracyclines, and fluoroquinolones.
What makes this discovery particularly significant is how the bacterium acquired these resistance genes. The researchers found that these dangerous traits are often attached to mobile genetic elements, such as plasmids and transposons. These are like genetic vehicles that can jump between bacteria, allowing them to share survival skills rapidly. The strain also carries a plasmid, a small ring of DNA separate from the main genome, which acts as a delivery truck for these resistance genes. This plasmid contains the machinery needed to transfer itself to other bacteria, potentially spreading the resistance to other strains in the environment or within the human gut. The presence of these mobile elements suggests that this bacterium is not just resistant on its own, but is also a potential distributor of resistance to others.
Beyond resistance, the study looked at how this bacterium causes disease. The genetic analysis confirmed the presence of a Type III secretion system, a molecular machine that acts like a syringe to inject toxic proteins directly into human cells. This system is a key weapon that allows the bacteria to invade the intestinal lining and cause the severe diarrhea and inflammation associated with shigellosis. The bacterium also possesses genes that help it stick to cells, steal iron from the host, and evade the immune system. These features indicate that the strain is well-equipped to infect humans, raising the possibility that poultry could serve as a reservoir for infections that eventually reach people.
The researchers also examined how this bacterium defends itself against viruses that attack bacteria, known as phages. They found that the strain has a sophisticated immune system, including CRISPR-Cas arrays, which function like a biological memory bank. This system allows the bacterium to remember past viral attacks and destroy the genetic material of any virus that tries to infect it again. This defense mechanism helps the bacterium survive in a crowded microbial environment where viruses are constantly trying to invade. The study also identified several prophages, which are viral genes that have integrated into the bacterial DNA. These viral remnants can sometimes carry new genes that benefit the bacteria, further contributing to its ability to adapt and evolve.
By comparing the genetic makeup of this poultry-derived strain with other Shigella and E. coli strains from around the world, the researchers found that it is closely related to human-infecting strains. The genetic similarity suggests that the bacteria found in chickens and those found in humans share a common evolutionary path and can exchange genetic material. The study highlights that the genome of this bacterium is "open," meaning it is constantly acquiring new genes from its environment rather than staying static. This flexibility allows it to adapt quickly to new challenges, such as the use of antibiotics in farming.
The findings serve as a clear signal that the poultry industry in Bangladesh, and potentially elsewhere, needs to pay closer attention to antibiotic use and biosecurity. The presence of a multidrug-resistant Shigella strain in chickens indicates that the environment where humans and animals interact is a hotspot for the development and spread of resistant bacteria. The researchers emphasize that a "One Health" approach, which considers the health of people, animals, and the environment as interconnected, is necessary to manage this risk. By monitoring these bacteria and understanding their genetic capabilities, public health officials can better predict and prevent outbreaks, ensuring that antibiotics remain effective for future generations. This study provides the first genomic blueprint for this specific strain, offering a foundation for future surveillance and control efforts.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.